Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc vs Probiotics in Neonatal Indirect Hyperbilirubinemia
NCT07102836Phase 2Recruiting
- Sponsor
- Quaid-e-Azam Medical College
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of zinc, Lactobacillus rhamnosus GG in neonatal hyperbilirubinemia, sponsored by Quaid-e-Azam Medical College. Started Aug 2025; status: recruiting.
02
Drugs
zincLactobacillus rhamnosus GG
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT07102836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07102836.